Glucotrack (GCTK) Income from Continuing Operations (2010 - 2025)
Glucotrack (GCTK) posted Income from Continuing Operations of 3419000.0 for Q4 2025, up 21.37% on a QoQ basis from 4348000.0 in Q3 2025, and up 11.86% year-over-year from 3056533.99 in Q4 2024.
Glucotrack (GCTK) Income from Continuing Operations (2010 - 2025) Analysis & Trends
Glucotrack's Income from Continuing Operations history runs 15 years deep, the most recent figure standing at 3419000.0 for Q4 2025.
- Quarterly Income from Continuing Operations rose 11.86% year-over-year to 3419000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 16142000.0 (down 9.47% YoY) and the FY2025 annual result came in at 16142000.0, down 10.47% from the prior year.
- Income from Continuing Operations was 3419000.0 for Q4 2025 at Glucotrack, up from 4348000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 838000.0 in Q3 2021 and bottomed at 4873000.0 in Q2 2025.
- A 5-year average of 2335550.0 and a median of 1886000.0 in 2021 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2021 — Income from Continuing Operations increased 20.08% — and 2024, when it tumbled 287.7%.
- Glucotrack's Income from Continuing Operations stood at 1548000.0 in 2021, then grew by 16.86% to 1287000.0 in 2022, then slumped by 88.58% to 2427000.0 in 2023, then plunged by 59.83% to 3879000.0 in 2024, then climbed by 11.86% to 3419000.0 in 2025.
- Business Quant data shows GCTK's Income from Continuing Operations at 3419000.0 in Q4 2025, 4348000.0 in Q3 2025, and 4873000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 240.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -37.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 13.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Glucotrack | 33.48 | -7.38 Mn | - | -3.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.42 Mn |
| Sep 30, 2025 | -4.35 Mn |
| Jun 30, 2025 | -4.87 Mn |
| Mar 31, 2025 | -3.50 Mn |
| Dec 31, 2024 | -3.88 Mn |
| Sep 30, 2024 | -3.26 Mn |
| Jun 30, 2024 | -4.57 Mn |
| Mar 31, 2024 | -3.04 Mn |
| Dec 31, 2023 | -2.43 Mn |
| Sep 30, 2023 | -2.22 Mn |
| Jun 30, 2023 | -1.18 Mn |
| Mar 31, 2023 | -1.28 Mn |
| Dec 31, 2022 | -1.29 Mn |
| Sep 30, 2022 | -930,000.00 |
| Jun 30, 2022 | -1.12 Mn |
| Mar 31, 2022 | -1.09 Mn |
| Dec 31, 2021 | -1.55 Mn |
| Sep 30, 2021 | -838,000.00 |
| Jun 30, 2021 | -981,000.00 |
| Mar 31, 2021 | -910,000.00 |